The pleiotropic role of interleukin-17 in atherosclerosis
- 1 October 2018
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 106, 1412-1418
Abstract
No abstract availableKeywords
This publication has 114 references indexed in Scilit:
- T helper 17 cell heterogeneity and pathogenicity in autoimmune diseaseTrends in Immunology, 2011
- Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of RORγt ProteinJournal of Biological Chemistry, 2011
- Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligandNature, 2011
- Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activityNature, 2011
- Functional Specialization of Interleukin-17 Family MembersImmunity, 2011
- IL-37 is a fundamental inhibitor of innate immunityNature Immunology, 2010
- Structure and signalling in the IL-17 receptor familyNature Reviews Immunology, 2009
- Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine modelAtherosclerosis, 2008
- TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt functionNature, 2008
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006